Octreotide Injection and Paliperidone: Interaction Details
AI-assisted, pharmacist-reviewed · Source data updated Aug 8, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Paliperidone
Octreotide Injection
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
What happens
An increased risk of QT interval prolongation and torsade de pointes
Interaction Deep Dive
Both octreotide and paliperidone have been associated with QT interval prolongation123. Avoid coadministration of paliperidone with octreotide due to the potential for additive effects on the QT interval 23.
Why it happens (mechanism)
Additive QT interval prolongation
Common questions
Can I take Octreotide Injection and Paliperidone together?
An increased risk of QT interval prolongation and torsade de pointes Always confirm with your pharmacist or prescriber before making any change.
How serious is the Octreotide Injection and Paliperidone interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Octreotide Injection or Paliperidone need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (3)
- Product Information: Sandostatin LAR(R) Depot IM injectable suspension, octreotide acetate IM injectable suspension. Novartis Pharmaceuticals Corporation (per FDA), East Hanover, NJ, 2011.
- Product Information: ERZOFRI(R) intramuscular extended-release injectable suspension, paliperidone palmitate intramuscular extended-release injectable suspension. Luye Pharma (USA) Ltd (per FDA), Princeton, NJ, 2024.
- Product Information: INVEGA SUSTENNA(R) intramuscular extended-release injectable suspension, paliperidone palmitate intramuscular extended-release injectable suspension. Janssen Pharmaceuticals Inc (per FDA), Titusville, NJ, 2021.
Keep reading about Paliperidone
Keep reading about Octreotide Injection
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist